Information  X 
Enter a valid email address

Synairgen PLC Ord 1P (SNG)

Date Time Source Announcement
28 Jun 2018 7:00 am
RNS
Positive SNG001 Biomarker Data in COPD Patients
26 Jun 2018 1:05 pm
RNS
Holding(s) in Company
22 Jun 2018 11:42 am
RNS
Result of AGM
  7:00 am
RNS
Synairgen Safety Data with SNG001 in COPD Patients
17 May 2018 7:00 am
RNS
Posting of Annual Report and Notice of AGM
16 Apr 2018 4:29 pm
RNS
Holding(s) in Company
06 Apr 2018 12:14 pm
RNS
Grant of Options
03 Apr 2018 5:21 pm
RNS
Holding(s) in Company
15 Mar 2018 3:13 pm
RNS
Issue of Equity
  3:11 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Preliminary results for year ended 31 Dec 2017
07 Feb 2018 7:00 am
RNS
Synairgen starts dosing in Phase II COPD study
14 Dec 2017 7:00 am
RNS
Update on LOXL2 Programme&Pharmaxis Collaboration
08 Nov 2017 4:31 pm
RNS
Holding(s) in Company
27 Sep 2017 7:00 am
RNS
Data update and clinical plan for COPD
  7:00 am
RNS
Interim results for six months ended 30 June 2017
13 Sep 2017 12:44 pm
RNS
Holding(s) in Company
06 Sep 2017 7:00 am
RNS
LOXL2 Inhibitor Update.
28 Jun 2017 12:41 pm
RNS
Result of AGM
05 Jun 2017 7:00 am
RNS
Posting of Annual Report and Notice of AGM
17 May 2017 7:00 am
RNS
Preliminary Results
27 Apr 2017 7:00 am
RNS
AZD9412 Update
27 Mar 2017 7:00 am
RNS
Holding(s) in Company
13 Mar 2017 3:10 pm
RNS
Holding(s) in Company
10 Mar 2017 8:34 am
RNS
Additional Positive Data in Lung Fibrosis
17 Jan 2017 2:46 pm
RNS
Holding(s) in Company
13 Oct 2016 10:44 am
RNS
Holding(s) in Company
12 Oct 2016 7:00 am
RNS
AZD9412 Clinical Trial Update
22 Sep 2016 7:00 am
RNS
Interim results for six months ended 30 June 2016
08 Sep 2016 7:00 am
RNS
Notice of Interim Results
14 Jun 2016 12:00 pm
RNS
Result of AGM
17 May 2016 7:00 am
RNS
Posting of Annual Report and Notice of AGM
21 Apr 2016 2:14 pm
RNS
Holding(s) in Company
23 Mar 2016 7:00 am
RNS
Exercise of Options
22 Mar 2016 7:00 am
RNS
Preliminary results for the year ended 31 Dec 2015
  7:00 am
RNS
Positive LOXL2 results
03 Mar 2016 7:00 am
RNS
Notice of Preliminary Results
16 Nov 2015 4:11 pm
RNS
Adoption of FRS 101 - Reduced Disclosure Framework
13 Nov 2015 3:08 pm
RNS
Holding(s) in Company
  11:41 am
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
12 Nov 2015 7:00 am
RNS
Directors' Share Purchase
28 Oct 2015 7:00 am
RNS
Grant of options
16 Sep 2015 7:00 am
RNS
Interim Results
21 Aug 2015 7:00 am
RNS
Notice of Interim Results
05 Aug 2015 7:00 am
RNS
Synairgen announces research collaboration
22 Jul 2015 7:00 am
RNS
AstraZeneca commences Phase II Trial
  7:00 am
RNS
AstraZeneca commences Phase II Trial
22 Jun 2015 1:41 pm
RNS
Result of AGM
02 Jun 2015 9:37 am
RNS
Holding(s) in Company
15 May 2015 11:04 am
RNS
Notice of AGM
22 Apr 2015 5:03 pm
RNS
Posting of Annual Report and Accounts
05 Mar 2015 12:55 pm
RNS
Richard Griffiths increases stake to 6.1 percent
03 Mar 2015 7:00 am
RNS
Preliminary Results
12 Feb 2015 12:44 pm
RNS
Holding(s) in Company
11 Nov 2014 2:34 pm
RNS
Exercise of options
04 Nov 2014 7:00 am
RNS
Grant of Options
08 Oct 2014 7:00 am
RNS
Exercise of options
25 Sep 2014 7:00 am
RNS
Interim results for the six months ended 30 June
17 Sep 2014 7:00 am
RNS
Notice of Interim Results
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t